title: Dramatic Reduction in Tumor Size During 5 Months of Pazopanib Therapy in Combination With Ifosfamide, Carboplatin, and Etoposide in an Early Infant With Progressive Soft Tissue Sarcoma.
authors.affiliation: Department of *Pediatrics ‡Dentistry and Oral Surgery §Radiology, Shinshu University School of Medicine †Department of Laboratory Medicine Shinshu University Hospital, Matsumoto ∥Department of Head and Neck Surgery Tokyo Medical and Dental University Tokyo, Japan.
authors.forename: Tatsuo
authors.initials: T
authors.lastname: Watanabe
authors.forename: Takashi
authors.initials: T
authors.lastname: Kurata
authors.forename: Kenji
authors.initials: K
authors.lastname: Sano
authors.forename: Shigeru
authors.initials: S
authors.lastname: Suzuki
authors.forename: Tomoki
authors.initials: T
authors.lastname: Kaneko
authors.forename: Mitsuo
authors.initials: M
authors.lastname: Motobayashi
authors.forename: Tomonari
authors.initials: T
authors.lastname: Shigemura
authors.forename: Takuro
authors.initials: T
authors.lastname: Sumi
authors.forename: Kenichi
authors.initials: K
authors.lastname: Koike
authors.forename: Yozo
authors.initials: Y
authors.lastname: Nakazawa
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D007191:Indazoles; D007223:Infant; D008297:Male; D011743:Pyrimidines / Q000008:administration & dosage; D012074:Remission Induction; D012509:Sarcoma / Q000188:drug therapy* / Q000473:pathology; D013449:Sulfonamides / Q000008:administration & dosage
chemical_list: D007191:Indazoles; D011743:Pyrimidines; D013449:Sulfonamides; D005047:Etoposide; C516667:pazopanib; D016190:Carboplatin; D007069:Ifosfamide